ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 25 of 44
Up
JMBS 2022, 7(3): 171–176
https://doi.org/10.26693/jmbs07.03.171
Clinical Medicine

Frequency of Occurrence and Clinical Picture of Urolithiasis on the Background of Benign Prostatic Hyperplasia

Mirzayev I. M.
Abstract

The purpose of the study was to identify the frequency of occurrence of urolithiasis against the background of benign prostatic hyperplasia, to find out whether the presence of benign prostatic hyperplasia in a patient affects the frequency of occurrence of urolithiasis, to study the clinical picture to understand whether there is some general or specific clinical picture or some feature inherent in the clinic when occurrence of urolithiasis and benign prostatic hyperplasia are accompanying each other. Materials and methods. The clinical data of 152 patients aged over 45 years who underwent examination and treatment in 2005-2015 at the A. Aliyev Azerbaijan State Institute of Advanced Medical Training and at the Shirvan Medical Diagnostic Center in 2008-2015 were analyzed. Against the background of benign prostatic hyperplasia, 85 (55.92%) patients had upper urinary tract stones. Of these, 52 (34.21%) had kidney stones, and 33 (21.71%) had ureteral stones. Bilateral nephrolithiasis was detected in 16 (10.5%) patients, unilateral – in 36 (23.68%), bilateral ureterolithiasis – in 2 (1.32%), unilateral – in 31 (20.39%) patients. Of 152 patients, bladder stones were detected in 112 (73.4%) patients. The bulk of the examined patients were patients who had bladder stones on the background of benign prostatic hyperplasia. Of these 112 patients, 25 (16.45%) had kidney stones along with cystolithiasis, one (0.89%) had left-sided ureterolithiasis, and one (0.89%) had bilateral nephrolithiasis and left-sided ureterolithiasis. To characterize the clinical signs of infravesical obstruction in benign prostatic hyperplasia, the Guyon classification was applied. Most of the patients – 102 (67.12%) patients according to this classification were at the II stage of benign prostatic hyperplasia. The number of patients at stage I was 29 (19.08%), and at stage III – 21 (13.82%). Results and discussion. In this study in patients over 45 years, nephrolithiasis on the background of benign prostatic hyperplasia was detected in 34.21% of cases, ureterolithiasis on the background of benign prostatic hyperplasia – in 21.71% of cases, cystoliasis on the background of benign prostatic hyperplasia – in 73.4% of cases, and cystolithiasis and upper urinary stones on the background of benign prostatic hyperplasia – in 17.8% of cases. As can be seen from the data presented, the bulk of the examined patients were patients who had bladder stones on the background of benign prostatic hyperplasia. Conclusion. The presence of bladder outlet obstruction and the aggravation of the stage of benign prostatic hyperplasia increase the incidence of cystolithiasis and aggravate the clinical picture of urolithiasis, leading to its complications. At the same time, the presence of concomitant urolithiasis aggravates the clinical picture of benign prostatic hyperplasia, that is, there is a syndrome of mutual weighing of clinical symptoms. There is no general and specific clinical picture in the clinic. There are the same signs and complications that are inherent in both pathologies. Therefore, there is a need for a deeper study of such patients for the correct diagnosis and choice of a rational method of treatment

Keywords: urolithiasis, benign prostatic hyperplasia, infravesical obstruction, dysuria, renal colic, lower urinary tract symptom

Full text: PDF (Eng) 255K

References
  1. Javadzadeh ShM, Huseynov XS. Dyshormogenetic prostate hyperplasia (DPH), clinical characteristics and modern treatment methods. Akad M Javad Mir Javad – Collection of works dedicated to the 80th anniversary of Javadzadeh. Baku; 2007. 2007. p. 20-26.
  2. Goloshchapov ET, Al’-Shukri SKh, Emanuel’ VL. Sovremennye predstavleniya o patogeneze mochevogo kamneobrazovaniya [Modern ideas about the pathogenesis of urinary stone formation] Urologicheskie vedomosti. 2015;5(1):95-96. [Russian]. https://doi.org/10.17816/uroved5195-96
  3. Agenosov MP, Kagan OF, Kheyfets VKh. Osobennosty klynycheskogo techenyya mochekamennoy bolezny u lyts pozhylogo y starcheskogo vozrasta [Features of the clinical course of urolithiasis in elderly and senile people] Urologycheskye vedomosty. 2017;7(4):53–59. [Russian]. https://doi.org/10.17816/uroved7453-59
  4. Al’-Shukri SKh, Slesarevskaya MN, Kuz’min IV. Litoliticheskaya terapiya uratnoho nefrolitiaza [Litolytic therapy of urate nephrolothiasis]. Urologiia. 2016;(2):23-27. [Russian]
  5. Dzhavadzade SM. Mochekamennaya bolezn v endemycheskom regyone [Urolithiasis in an endemic region]. Baku: Voennoe yzdatelstvo; 1996. 126 s. [Russian]
  6. Mammadov C, Fiqarov İ, Javad-Zadeh S, İsmayılov İ, Aliyev R, Orucova L. The clinical diaqnosis and treatment of kidney stone disease protokol. Baku: Mega polygraph; 2010. p. 7-27.
  7. Gomberg VG. Urologicheskaya pomoshch’ lyudyam pozhilogo i starcheskogo vozrasta s razlichnoi patologiei mocheispuskaniya [Urological care for elderly and senile people with various pathologies of urination]. Urologicheskie vedomosti. 2015;5(1):79-80. [Russian]. https://doi.org/10.17816/uroved5179-80
  8. Strotskyy AV, Nechyporenko NA, Zhebentyaev AA. Urologyya [Urology]. Ucheb. Pod red AV Strotskyy. M: Novoe znanye; 2016. 228 s. [Russian]
  9. Ymamverdyev SB , Guseyn-zade RT . Faktory ryska mochekamennoy bolezny po dannym Gusarskogo y Khachmazskogo rayonov Azerbaydzhanskoy respublyky [Risk factors of urolithiasis according to the Gusar and Khachmaz districts of the Republic of Azerbaijan]. Kazanskyy medytsynskyy zhurnal. 2014;95(1):100-103. [Russian]. https://doi.org/10.17816/KMJ1466
  10. Dutov VV. Sovremennye aspekty dyagnostyky y lechenyya mochekamennoy bolezny u patsyentov pozhylogo y starcheskogo vozrasta [Modern aspects of the diagnosis and treatment of urolithiasis in elderly and senile patients]. RMZh. 2014;29:21. [Russian]
  11. Kaurov BA, Matyukhyna EB. Gendernye osobennosty polymorbydnosty u lyudey pozhylogo vozrasta y dolgozhyteley [Gender features of polymorbidity in elderly people and centenarians]. Klynycheskaya gerontologyya. 2013;19(9-10):52. [Russian]
  12. Mitchel L. Benign prostatic hyperplasia: Clinical Urology. Hayle Medical; 2020. 199 p.
  13. Sigurjonsdottir VK, Runolfsdottir HL, Idridason OS, Palsson R, Edvardsson VO. Impact of nephrolithiasis on kindey function. BMC Nephrol. 2015 Aug 28;16:149. PMID: 26316205. PMCID: PMC4551564. https://doi.org/10.1186/s12882-015-0126-1
  14. Dragutsa IM, Zabrodina NB. Nekotorye osobennosti klinicheskikh proyavleniy, dinamiki zabolevaniya u bolnykh urolitiazom razlichnykh vozrastnykh grupp [Some features of clinical manifestations, dynamics of the disease in patients with urolithiasis of different age groups]. Meditsinskii vestnik MVD. 2012;(4):51-56. [Russian]
  15. Alyaev YuG, Saenko VS, Sorokyn NY. Mochekamennaya bolezn. Sovremennye metody dyagnostyky y lechenyya [Urolithiasis. Modern methods of diagnosis and treatment]. Pod red YuG Alyaev. M: GEOTAR- Medya; 2010. 224 p. [Russian]
  16. Lopatkyn NA. Urologyya. Natsyonalnoe rukovodstvo [Urology. National leadership] Kratkoe izdanye. Pod red NA Lopatkyna. M: GEOTAR- Medya; 2013. 608 p. [Russian]
  17. Cho ST, Jung SI, Myung SC, Kim TH. Correlation of metabolic syndrome with urinary stone composition. Int J Urol. 2013;20(2): 208-213. PMID: 23020870. https://doi.org/10.1111/j.1442-2042.2012.03131.x